Friday, August 17, 2018
 
 
Company News: Page (1) of 1 - 09/13/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Global Medical Image Analysis Integrated & Standalone Market To Reach US$ 3.6 Billion By 2022

(September 13, 2017)
By Jack Matt

The global medical image analysis integrated & standalone market is expected to exceed US$ 3.6 billion by 2022, registering a compound annual growth rate (CAGR) of more than 7.5% during the forecast period. The technological advancements in medical imaging systems and analysis software and growing investments by public and private sectors in the medical imaging market are expected to drive the market. In addition, the fusion of imaging technologies and increasing use of imaging equipment are fueling the growth of the market. However, budgetary constraints and hacking-related risks associated with the use of imaging equipment and software are hampering the growth of the market.

In this report, the global medical image analysis integrated & standalone market is segmented by type, modality, application, end user, and region. On the basis of type, the market is segmented into integrated software and stand-alone software. The market on the basis of modality is segmented into tomography, ultrasound imaging, radiographic imaging, and combined modalities. Based on application, the market is segmented into orthopedic, dental, cardiology, oncology, neurology, mammography, obstetrics & gynecology, and urology & nephrology. The market by end user is segmented into hospitals, diagnostic centers, and research centers.

The global medical image analysis integrated & standalone market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, and Rest of the World. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional market and analyzes the variations in the growth of the industry in certain regions.



A glimpse of the report structure is provided in the report description available on the website.

https://www.marketresearchengine.com/reportdetails/medical-image-analysis-integrated-and-standalone-market

Agfa HealthCare (Belgium), Aquilab (France), Carestream Health, Inc. (U.S.), Esaote S.p.A (Italy), GE Healthcare (U.K.), Merge Healthcare, Inc. (U.S.), MIM Software Inc. (U.S.), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), and Toshiba Medical Systems Corporation (Japan) are the key players in the medical image analysis integrated & standalone market.

This report covers the medical image analysis integrated & standalone market, in terms of value, and forecasts the market size till 2022. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

The deep-dive study on the medical image analysis integrated & standalone market will help customers with identifications of new market opportunities and targeted promotional plans.

 

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [email protected]

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

 

Source: http://www.financeswire.com/global-medical-image-analysis-integrated-standalone-market-to-reach-us-3-6-billion-by-2022


Page: 1


Related Keywords:Health and Medicine,Market,News,Global Medical Image Analysis Integrated & Standalone Market,
Related Sites: DMN Newswire ,   itbusinessnet.com ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines